Phase 2 Results Of Oxford Astrazeneca Vaccine Trial Show Promising Results

Scientists in England say the latest results of the Oxford COVID-19 vaccine show it's safe and provokes an immune response. It joins a growing list of vaccine candidates that have proven successful and may soon be rushed out for distribution. Charlie D'Agata reports from Oxford.

  • Phase 2 results of Oxford, AstraZeneca vaccine trial show promising results ( Download)
  • COVID-19: AstraZeneca-Oxford vaccine shows promising results among elderly ( Download)
  • AstraZeneca reports more promising COVID-19 vaccine results ( Download)
  • AstraZeneca-Oxford COVID-19 vaccine up to 90% effective, late stage trials show ( Download)
  • Coronavirus vaccine trial shows promising results but hurdles remain ( Download)
  • Oxford University’s COVID-19 Vaccine Shows Promising Results In Phase 1 and 2 Trials ( Download)
  • Oxford COVID-19 vaccine shows promise ( Download)
  • Oxford University coronavirus vaccine trials show promising results | ABC News ( Download)
  • Reaction as Oxford vaccine trial results look promising | Coronavirus ( Download)
  • AstraZeneca Covid Vaccine Triggers Strong Immune Response in Elderly: Oxford ( Download)
  • Oxford University vaccine results show strong immune response in older demographic ( Download)
  • Oxford Coronavirus Vaccine Shows Promising Results | NBC Nightly News ( Download)
  • AstraZeneca-Oxford First To Publish Final-Stage Vaccine Trial Results ( Download)
  • Oxford-AstraZeneca COVID-19 vaccine found to be between 70% and 90% effective ( Download)
  • AstraZeneca vaccine producing positive results in older Australians ( Download)